1-Prop-2-ynyl-8-((E)-styryl)-3,7-dihydro-purine-2,6-dione | 199680-53-0

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 咪唑并嘧啶类
• 英文名称: 1-Prop-2-ynyl-8-((E)-styryl)-3,7-dihydro-purine-2,6-dione
• 英文别名: 8-[(E)-2-phenylethenyl]-1-prop-2-ynyl-3,7-dihydropurine-2,6-dione
• CAS: 199680-53-0
• 化学式: C₁₆H₁₂N₄O₂
• 分子量: 292.297
• InChiKey: MXXBRYVSNYZVLB-CMDGGOBGSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.9
• 重原子数：
  22
• 可旋转键数：
  3
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.06
• 拓扑面积：
  78.1
• 氢给体数：
  2
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  1-Prop-2-ynyl-8-((E)-styryl)-3,7-dihydro-purine-2,6-dione 、 碘甲烷 在 potassium carbonate 作用下， 以 N,N-二甲基甲酰胺 为溶剂， 反应 12.0h， 以93%的产率得到8-styryl-DMPX
  参考文献：
  名称：

  Synthesis and Structure−Activity Relationships of 3,7-Dimethyl-1-propargylxanthine Derivatives, A_2A-Selective Adenosine Receptor Antagonists

  摘要：

  A series of 8-substituted derivatives of 3,7-dimethyl-1-propargylxanthine (DMPX) was synthesized and investigated as A(2A) adenosine receptor antagonists. Different synthetic strategies for the preparation of DMPX derivatives and analogues were explored. A recently developed synthetic procedure starting from 3-propargyl-5,6-diaminouracil proved to be the method of choice for the preparation of this type of xanthine derivatives. The novel compounds were investigated in radioligand binding studies at the high-affinity adenosine receptor subtypes A(1) and A(2A) and compared with standard A(2A) adenosine receptor antagonists. Structure-activity relationships were analyzed in detail. 8-Styryl-substituted DMPX derivatives were identified that exhibit high affinity and selectivity for A(2A) adenosine receptors, including 8-(m-chlorostyryl)-DMPX (CS-DMPX, K-i A(2A) = 13 nM, 100-fold selective), 8-(m-bromostyryl)-DMPX (BS-DMPX, K-i A(2A) = 8 nM, 146-fold selective), and 8-(3,4-dimethoxystyryl)-DMPX (K-i A(2A) = 15 nM, 167-fold selective). These and other novel compounds are superior to the standard A(2A) adenosine receptor antagonists KF17837 (4) and CSC (5) with respect to A(2A) affinity and/or selectivity.

  DOI：

  10.1021/jm970515+
• 作为产物：
  描述：

  5,6-diamino-3-prop-2-ynyl-1H,3H-pyrimidine-2,4-dione 在 氯化亚砜 、 溶剂黄146 作用下， 以 甲醇 为溶剂， 反应 1.5h， 生成 1-Prop-2-ynyl-8-((E)-styryl)-3,7-dihydro-purine-2,6-dione
  参考文献：
  名称：

  Synthesis and Structure−Activity Relationships of 3,7-Dimethyl-1-propargylxanthine Derivatives, A_2A-Selective Adenosine Receptor Antagonists

  摘要：

  A series of 8-substituted derivatives of 3,7-dimethyl-1-propargylxanthine (DMPX) was synthesized and investigated as A(2A) adenosine receptor antagonists. Different synthetic strategies for the preparation of DMPX derivatives and analogues were explored. A recently developed synthetic procedure starting from 3-propargyl-5,6-diaminouracil proved to be the method of choice for the preparation of this type of xanthine derivatives. The novel compounds were investigated in radioligand binding studies at the high-affinity adenosine receptor subtypes A(1) and A(2A) and compared with standard A(2A) adenosine receptor antagonists. Structure-activity relationships were analyzed in detail. 8-Styryl-substituted DMPX derivatives were identified that exhibit high affinity and selectivity for A(2A) adenosine receptors, including 8-(m-chlorostyryl)-DMPX (CS-DMPX, K-i A(2A) = 13 nM, 100-fold selective), 8-(m-bromostyryl)-DMPX (BS-DMPX, K-i A(2A) = 8 nM, 146-fold selective), and 8-(3,4-dimethoxystyryl)-DMPX (K-i A(2A) = 15 nM, 167-fold selective). These and other novel compounds are superior to the standard A(2A) adenosine receptor antagonists KF17837 (4) and CSC (5) with respect to A(2A) affinity and/or selectivity.

  DOI：

  10.1021/jm970515+

文献信息

• CYCLOHEXANE DERIVATIVES AND USES THEREOF
  申请人：BARNES David

  公开号：US20110136735A1

  公开（公告）日：2011-06-09

  The present invention provides a compound of formula I; a method for manufacturing the compounds of the invention, and its therapeutic uses. The present invention further provides a combination of pharmacologically active agents and a pharmaceutical composition.

  本发明提供了一种I式化合物；一种制造本发明化合物的方法及其治疗用途。本发明还提供了一种药理活性剂的组合和制药组合物。
• [EN] 3-SUBSTITUTED XANTHINE DERIVATIVES AS MRGPRX4 RECEPTOR MODULATORS<br/>[FR] DÉRIVÉS DE XANTHINE SUBSTITUÉS EN POSITION 3 UTILISÉS COMME MODULATEURS DU RÉCEPTEUR MRGPRX4
  申请人：UNIV BONN RHEINISCHE FRIEDRICH WILHELMS

  公开号：WO2022079245A1

  公开（公告）日：2022-04-21

  The invention relates to MRGPRX4 receptor agonists and antagonists useful for treating, alleviating and/or preventing diseases and disorders related to MRGPRX4 receptor function as well as pharmaceutical compositions comprising such compounds and methods for preparing such compounds. The invention is further directed to the use of these compounds, alone or in combination with other therapeutic agents, for alleviating, preventing and/or treating diseases and disorders, especially the use as wound healing medicaments and for the treatment of chronic pain and itch.

  该发明涉及用于治疗、缓解和/或预防与MRGPRX4受体功能相关的疾病和紊乱的MRGPRX4受体激动剂和拮抗剂，以及包括这些化合物的药物组合物和制备这些化合物的方法。该发明进一步涉及使用这些化合物，单独或与其他治疗剂联合使用，用于缓解、预防和/或治疗疾病和紊乱，特别是用作伤口愈合药物和治疗慢性疼痛和瘙痒的用途。
• CYCLOHEXANE DERIVATIVES AS INHIBITORS OF ACETYL-COA CARBOXYLASE (ACC)
  申请人：Novartis AG

  公开号：EP2507210A1

  公开（公告）日：2012-10-10
• US8394858B2
  申请人：——

  公开号：US8394858B2

  公开（公告）日：2013-03-12
• [EN] CYCLOHEXANE DERIVATIVES AS INHIBITORS OF ACETYL-COA CARBOXYLASE (ACC)<br/>[FR] DÉRIVÉS DE CYCLOHEXANE COMME INHIBITEURS DE L'ACÉTYL-COA CARBOXYLASE (ACC)
  申请人：NOVARTIS AG

  公开号：WO2011067306A1

  公开（公告）日：2011-06-09

  The present invention provides a compound of formula (I) a method for manufacturing the compounds of the invention, and its therapeutic uses. The present invention further provides a combination of pharmacologically active agents and a pharmaceutical composition.